US stocks markets ended the pre-holiday week by booking solid gains on Friday, after five sessions that saw trade marked by a rare slowdown in bad news from Europe and further evidence of a US recovery.
The major indices began the week in the red amid lingering concerns that the European Central Bank would not step in to stop the eurozone rot.
However, they managed to eke out solid gains by Friday’s close.
While the Frankfurt-based central bank continued to shy away from backing indebted sovereigns, it did open lending windows for European banks, which helped ease panic.
“The signs are encouraging in Europe,” Hugh Johnson of Hugh Johnson Advisors said. “There are some signs, not overwhelming, that things are starting to stabilize in Europe.”
The Dow Jones Industrial Average finished up 3.6 percent to end the week at 12,294.00 points.
The NASDAQ was up 2.5 percent for the period and the S&P 500 added 3.7 percent for the week.
Stocks were helped by suggestions on Tuesday of a nascent turnaround in the US housing industry, with new home starts up 9.3 percent last month from a year earlier to the best level since April last year, when since-expired government tax credits were driving sales.
“The surge in sales ... suggests the sector is beginning to wake from its long sleep; expect sustained gains in sales and starts ahead,” Ian Shepherdson of High Frequency Economics said.
On Thursday, US stocks scored solid gains on encouraging jobs market data.
Weekly claims for US unemployment benefits fell to the lowest level since April 2008 last week, the US Department of Labor said.
Data from Germany also set a more positive tone.
Germany’s Ifo business sentiment index defied analysts’ expectations and rose to 107.2 points this month from 106.6 last month.
“There can be no talk of a crash as in 2008,” Ifo Institute president Hans-Werner Sinn said.
Medigen Vaccine Biologics Corp (高端疫苗) yesterday reported higher neutralizing antibody levels in people who were given its COVID-19 vaccine as a booster after two AstraZeneca doses, the company said. In a trial of 200 participants who received Medigen’s COVID-19 vaccine, neutralizing antibodies against the Omicron variant of SARS-CoV-2 grew by 5.7 times one month after being administered, Taoyuan General Hospital said. Medigen said that the results have been submitted to medRxiv, an online platform for researchers to share complete but unpublished papers. Another trial conducted by National Taiwan University Hospital showed that among 45 participants who received three doses of the Medigen vaccine,
BEATING EXPECTATIONS: With electric vehicles and the metaverse on the horizon, the company predicts a solid first quarter as customers stockpile inventories Key iPhone assembler Hon Hai Precision Industry Co (鴻海精密) could achieve an “unprecedented” performance in the first quarter, chairman Young Liu (劉揚偉) said. “Our performance in the first quarter might surpass how we fared in the past few years, and it is likely that some staff at key sites might only get two days off during the Lunar New Year holiday,” Liu said in prepared remarks for the company’s annual workers’ party yesterday. Manufacturers around the world are racing to build up inventory out of fear that outbreaks of the Omicron variant of SARS-CoV-2 and other uncertainties could further disrupt their supply
The US Department of Commerce on Tuesday said that a global survey of semiconductor chip producers and users shows a shortage will persist, sparked primarily by wafer production capacity constraints. The voluntary survey of 150 companies last fall in the supply chain confirmed “there is a significant, persistent mismatch in supply and demand for chips, and respondents did not see the problem going away in the next six months.” US Secretary of Commerce Gina Raimondo told reporters that the department “in a few instances didn’t really get what we needed and we’re going to go company by company and do personal engagement
EV ‘ECOSYSTEM’: The firms have agreed to work with the Indonesian government and others in creating infrastructure for the country’s growing EV market Hon Hai Precision Industry Co (鴻海精密) yesterday made a major step toward a foothold in the world’s electric vehicle (EV) market by signing partnership agreements with the Indonesian government and local energy and battery companies, in which local EV supplier Gogoro Inc (睿能創意) would also take part. Hon Hai, the world’s largest electronics manufacturing company, signed a memorandum of understanding with the Indonesian Ministry of Investment, battery maker PT Industri Baterai Indonesia, PT Indika Energy and Gogoro to build a sustainable energy ecosystem in Indonesia, a joint statement said. The government-level deal came after Hon Hai last year unveiled its first EV